Entecavir
RxNorm 306266
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 306266 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: entecavir.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Entecavir
(Atom ID: 2180700)
PTPrescribable
Designated preferred name (PT):
Entecavir
(Atom ID: 2358401)
FNPrescribable
Full form of descriptor (FN):
Entecavir (substance)
(Atom ID: 2358403)
PTPrescribable
Designated preferred name (PT):
Entecavir-containing product
(Atom ID: 10802142)
FNPrescribable
Full form of descriptor (FN):
Product containing entecavir (medicinal product)
(Atom ID: 9256667)
Patient Education
Entecavir
Entecavir is used to treat chronic (long-term) hepatitis B infection (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have liver damage. Entecavir is in a class of medications called nucleoside analogs. It works by decreasing the amount of hepatitis B virus (HBV) in the body. Entecavir does not cure HBV and may not prevent complications of chronic hepatitis B such as cirrhosis of the liver or liver cancer. Entecavir does not prevent the spread of HBV to other people.
[Learn More]
* Please review the disclaimer below.